tradingkey.logo
tradingkey.logo
Search

Anavex Life Sciences Corp

AVXL
Add to Watchlist
2.420USD
+0.010+0.41%
Close 09-18 16:00ET
222.94MMarket Cap
LossP/E TTM

AVXL Financials

See Anavex Life Sciences Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
222.94M
Dividend TTM
0.00
P/E TTM
-5.17
EPS TTM
-0.46
Revenue
--
Net Profit
-46.38M
ROE
-33.63%
ROA
-31.08%

Anavex Life Sciences Corp Earnings Date

Latest Release
Aug 28, 2026
EPS / Forecast
-0.54/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
154.41%0.08
55.32%-0.06
16.51%-0.11
-7.36%-0.16
-2.90%-0.13
-35.94%-0.14
-10.73%-0.14
-3.59%-0.14
23.60%-0.13
36.85%-0.11
---0.12
---0.14
---0.17
---0.17
---0.62
----
----
----
----
----
Net Profit
159.08%7.82M
53.09%-5.68M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.20M
-40.47%-12.11M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
-21.95%-14.29M
-21.48%-12.37M
-27.99%-10.44M
-38.54%-10.88M
-96.44%-11.72M
-56.94%-10.18M
Debt to assets ratio
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
--0.00%
--0.00%
----
----
----
----
----
----
Operating profit
147.33%6.77M
48.75%-6.75M
20.13%-10.83M
-0.73%-14.31M
-2.18%-12.42M
-23.05%-13.17M
-13.18%-13.56M
-9.54%-14.20M
9.58%-12.15M
26.83%-10.70M
16.15%-11.98M
-10.10%-12.97M
-25.79%-13.44M
-34.02%-14.63M
-26.47%-14.29M
-17.86%-11.78M
-33.84%-10.68M
-34.28%-10.91M
-84.82%-11.30M
-47.23%-9.99M
Net Profit
159.08%7.82M
53.09%-5.68M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.20M
-40.47%-12.11M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
-21.95%-14.29M
-21.48%-12.37M
-27.99%-10.44M
-38.54%-10.88M
-96.44%-11.72M
-56.94%-10.18M
Current assets
17.29%120.14M
7.21%132.99M
-23.42%103.81M
-27.63%102.43M
-18.94%117.14M
-16.23%124.04M
-12.19%135.57M
-10.31%141.53M
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.70M
-3.72%160.22M
91.78%160.28M
188.76%156.90M
367.88%161.62M
426.14%166.42M
Total current liabilities
-32.96%7.69M
-51.47%6.37M
-41.54%8.95M
-2.38%11.47M
81.85%17.38M
5.07%13.13M
22.10%15.30M
6.32%11.75M
-31.83%9.56M
-5.68%12.49M
22.72%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.42%10.21M
2.27%9.48M
3.96%8.07M
31.06%10.53M
47.81%10.80M
33.45%9.27M
Total assets
17.29%120.14M
7.21%132.99M
-23.42%103.81M
-27.63%102.43M
-18.94%117.14M
-16.23%124.04M
-12.19%135.57M
-10.31%141.53M
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.70M
-3.72%160.22M
91.78%160.28M
188.76%156.90M
367.88%161.62M
426.14%166.42M
Total liabilities
-32.96%7.69M
-51.47%6.37M
-41.54%8.95M
-2.38%11.47M
81.85%17.38M
5.07%13.13M
22.10%15.30M
6.32%11.75M
-31.83%9.56M
-5.68%12.49M
22.72%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.42%10.21M
2.27%9.48M
3.96%8.07M
31.06%10.53M
47.81%10.80M
33.45%9.27M
Total equity
23.63%112.45M
14.16%126.62M
-21.12%94.87M
-29.91%90.96M
-26.08%99.76M
-18.19%110.92M
-15.22%120.26M
-11.57%129.78M
-7.03%134.96M
0.33%135.57M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
-5.52%142.49M
-4.08%150.74M
100.77%152.21M
216.12%146.37M
453.73%150.82M
536.71%157.15M
Net operating income
27.02%-9.10M
41.00%-7.15M
-29.23%-8.60M
-140.62%-12.46M
49.76%-5.86M
-65.62%-12.12M
-13.82%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-44.65%-5.85M
-8.49%-7.65M
11.94%-8.49M
-65.51%-5.79M
47.31%-4.04M
6.22%-7.05M
-31.74%-9.64M
55.52%-3.50M
-22.70%-7.67M
-85.97%-7.52M
Net financing
100.00%0.00
5030.37%36.32M
11155.06%10.02M
-147.10%-2.14M
-88.29%852.00K
1100.00%708.00K
-95.67%89.00K
-49.46%4.55M
-60.31%7.28M
-77.15%59.00K
84037.73%2.06M
30.28%9.00M
54.90%18.33M
-89.83%258.24K
-99.89%2.44K
-92.25%6.91M
-66.96%11.84M
-90.22%2.54M
-71.82%2.22M
1649.34%89.22M

FAQs

What are the current assets of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its current assets were 103.81M, with a year-on-year change of -23.42.

What are the total assets of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its total assets of Anavex Life Sciences Corp were 103.81M, with a year-on-year change of -23.42.

What are the total liabilities of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its total liabilities of Anavex Life Sciences Corp were 8.95M, with a year-on-year change of -41.54.

What is the total equity of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its total equity of Anavex Life Sciences Corp was 94.87M, with a year-on-year change of -21.12.

What is the net operating income of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its net operating income of Anavex Life Sciences Corp was -50.72M, with a year-on-year change of -0.42.

What is the net financing of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its net financing of Anavex Life Sciences Corp was 9.43M, with a year-on-year change of -21.22.

What is the Earnings Per Share (EPS) of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.54, with a year-on-year change of -5.55.

What is the net income of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its net income was -46.38M, with a year-on-year change of -7.85.

What is the Return on Equity (ROE) of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its Return on Equity (ROE) was -43.11, with a year-on-year change of -31.40.

What is the Return on Assets (ROA) of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its Return on Assets (ROA) was -38.75, with a year-on-year change of -30.63.

What is the operating profit of Anavex Life Sciences Corp?

According to Anavex Life Sciences Corp's FY2025 earnings report, its operating profit was -50.72M, with a year-on-year change of -0.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.